Snowball logo
logo
NVLG

Novolog Pharm-Up 1966 Ltd

NVLG TA
0.7650.00  (0%)
Estimate
P/E
76.5
EPS
0.01
Beta
0.157
Growth
Revenue, YoY
-0.2%
Net income, YoY
-56.32%
FCF, YoY
139.9%
Dividends
Div. yield, TTM
5.12%
Annual payout, TTM
0.04
Payout
619.24%
Div.growth, 5y
8.62%
Div.rating
About the company
Ticker
NVLG
ISIN
IL0011401515
Country
Israel
Sector (GICS)
Healthcare
Novolog (Pharm-Up 1966) Ltd provides healthcare services in Israel. The company operates through three divisions: Logistics, Healthcare Services, and Digital. The Logistics division engages in the import and distribution of pharmaceuticals and medical products; logistics of clinical trials and related services; provision of pharmaceutical services to customers; and sterilization and validation processes of consumable medical equipment. The Healthcare Services division provides personalized medicine, medical and diagnostic laboratory, and other medical services to patients, health organizations, insurance companies, multinational companies, and government bodies. The Digital division identifies and develops technological tools for health services; deals with making medical information accessible to the public through medical websites; promotes digital presence for clinics, doctors therapists, and medical bodies; provides services and management tools; and operates and markets digital platforms for doctors and clinics. In addition, the company provides appointment scheduling, calendar management, and telemedicine meeting management. Novolog (Pharm-Up 1966) Ltd was incorporated in 1966 and is headquartered in Modi'in-Maccabim-Re'ut, Israel.

Frequently asked questions

What sector does Novolog Pharm-Up 1966 Ltd (NVLG) operate in?

Novolog Pharm-Up 1966 Ltd belongs to the Healthcare sector and operates in the Medical Distribution industry.

What is Novolog Pharm-Up 1966 Ltd (NVLG) current stock price?

As of the latest data, Novolog Pharm-Up 1966 Ltd stock price is ₪0.77, with a previous close of ₪0.77.

What is Novolog Pharm-Up 1966 Ltd (NVLG) current market capitalization?

Novolog Pharm-Up 1966 Ltd market cap is approximately 390.82 million.

What is Novolog Pharm-Up 1966 Ltd (NVLG) Earnings Per Share (EPS)?

The trailing EPS is ₪0.01.

What is Novolog Pharm-Up 1966 Ltd (NVLG) Price-to-Earnings (P/E) ratio?

Novolog Pharm-Up 1966 Ltd current P/E ratio is 76.5.

What is Novolog Pharm-Up 1966 Ltd (NVLG) EBITDA?

Novolog Pharm-Up 1966 Ltd EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 21.38 million.

Does Novolog Pharm-Up 1966 Ltd (NVLG) pay dividends?

Yes. Novolog Pharm-Up 1966 Ltd pays semiannual dividends with an annualized yield of 5.12% and an estimated annual payout of ₪0.04 per share.

What is Novolog Pharm-Up 1966 Ltd (NVLG) beta (volatility) score?

Novolog Pharm-Up 1966 Ltd has a beta of 0.157, indicating lower volatility than the overall market.